Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study

Blood (2020) 136 (Supplement 1): 11.

https://doi.org/10.1182/blood-2020-136150

Published: 2020

Journal Articles

Prognostic Impact of Past History of Other Malignancies in Diffuse Large B Cell Lymphoma

Kazuna Tanba, MD, Yoshiaki Chinen, MDPhD, Hitoji Uchiyama, MD PhD, Nobuhiko Uoshima, MD PhD, Kazuho Shimura, MD PhD, Shin-ichi Fuchida, MD PhD, Miki Kiyota, MD PhD, Mitsushige Nakao, MD PhD, Yuji Shimura, MD PhD, Tsutomu Kobayashi, MD PhD, Shigeo Horiike, MD PhD, Katsuya Wada, MD PhD, Chihiro Shimazaki, MD PhD, Hiroto Kaneko, MD PhD, Yutaka Kobayashi, MD PhD, Masafumi Taniwaki, MD PhD, Junya Kuroda, MD PhD

Blood (2017) 130 (Supplement 1): 1570.

https://doi.org/10.1182/blood.V130.Suppl_1.1570.1570

Published: 2017

Journal Articles

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

Yoko Kado, BS, Fumiaki Kitazawa, MS, Masayuki Tsujimoto, PhD, Shin-ichi Fuchida, MD PhD, Akira Okano, MD PhD, Mayumi Hatsuse, MD, Satoshi Murakami, MD, Kumi Ueda, BS, Takatoshi Kokufu, BS, Shoichi Ozawa, Natsuko Ito, Satoe Morishita, Tetsuya Takada, BS, Tetsuya Minegaki, PhD, Kohshi Nishiguchi, PhD, Eishi Ashihara, MD PhD, Chihiro Shimazaki, MD PhD

Blood (2015) 126 (23): 3700.

https://doi.org/10.1182/blood.V126.23.3700.3700

Published: 2015

Journal Articles

Retrospective Analysis Of The Recent Treatment Strategies For The Patients With Myeloma-Related Diseases Registered In Kansai Myeloma Forum

Blood (2013) 122 (21): 3385.

https://doi.org/10.1182/blood.V122.21.3385.3385

Published: 2013

Journal Articles

Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65–70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network

Shuji Ozaki, MD, PhD, Takeshi Harada, MD, Takayuki Saitoh, M.D. Ph.D., Chihiro Shimazaki, MD, PhD, Mitsuhiro Itagaki, MD, Hideki Asaoku, MD, Yoshiaki Kuroda, MD, PhD, Takaaki Chou, MD, PhD, Yumiko Yoshiki, MD, Kenshi Suzuki, MD, PhD, Hirokazu Murakami, M.D., Ph.D., Kunihiko Hayashi, PhD, Antonio Palumbo, MD, Kazuyuki Shimizu, MD

Blood (2012) 120 (21): 5030.

https://doi.org/10.1182/blood.V120.21.5030.5030

Published: 2012

Journal Articles

Cyclin-Dependent Kinase Inhibitors Enhance Sensitivity to Methotrexate In Human T-Cell Leukemia Jurkat Cells

Hitoji Uchiyama, MD, PhD, Yoshihiro Sowa, PhD, Miki Wakada, Mayumi Yogosawa, Ryoko Nakanishi, MSc, Mano Horinaka, PhD, Chihiro Shimazaki, MD, PhD, Masafumi Taniwaki, MD, PhD, Toshiyuki Sakai, MD, PhD

Blood (2010) 116 (21): 3976.

https://doi.org/10.1182/blood.V116.21.3976.3976

Published: 2010

Journal Articles

Expression of Master Regulators of Helper T-Cell Differentiation in Peripheral T-Cell Lymphoma, Not Otherwise Specified by Immunohistochemical Analysis.

Yosuke Matsumoto, MD, PhD, Shigeo Horiike, MD, PhD, Muneo Ohshiro, MD, Mio Yamamoto, MD, Nana Sasaki, MD, Yasuhiko Tsutsumi, MD, Tsutomu Kobayashi, MD, Daisuke Shimizu, MD, PhD, Hitoji Uchiyama, MD, Junya Kuroda, MD, PhD, Kenichi Nomura, MD, PhD, Chihiro Shimazaki, MD, PhD, Masafumi Taniwaki, MD, PhD

Blood (2009) 114 (22): 5004.

https://doi.org/10.1182/blood.V114.22.5004.5004

Published: 2009

Journal Articles

ß-Catenin siRNA Successfully Suppressed the Progression of Multiple Myeloma in In Vivo Mouse Model.

Eri Kawata, MD, Eishi Ashihara, MD, PhD, Ruriko Tanaka, Asumi Yokota, Yoshihide Murotani, MD, Miki Taniguchi, MD, Yuri Kamitsuji, MD, Junya Kuroda, MD, PhD, Tohru Inaba, MD, PhD, Chihiro Shimazaki, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, PhD

Blood (2007) 110 (11): 2506.

https://doi.org/10.1182/blood.V110.11.2506.2506

Published: 2007

Journal Articles

Long-Term Survival after HLA-Haploidentical Stem Cell Transplantation from Non-Inherited Maternal Antigen-Mismatched Family Donors: Impact of Chronic Graft-Versus-Host Disease.

Tatsuo Ichinohe, MD, Chihiro Shimazaki, MD, Motohiro Hamaguchi, MD, Arata Watanabe, MD, Hiroyuki Ishida, MD, Takao Yoshihara, MD, Akira Morimoto, MD, Nobuhiko Uoshima, MD, Souichi Adachi, MD, Takeshi Inukai, MD, Akihisa Sawada, MD, Koji Oka, MD, Mitsuru Itoh, MD, Masayuki Hino, MD, Junya Kanda, MD, Takashi Uchiyama, MD, Yoshihisa Kodera, MD

Blood (2007) 110 (11): 5075.

https://doi.org/10.1182/blood.V110.11.5075.5075

Published: 2007

Journal Articles

Kinetics of Circulating Endothelial Progenitors in Patients with Sclerodermatous Chronic Graft-Versus-Host Disease.

Eishi Ashihara, MD, PhD, Kazuho Shimura, MD, Chihiro Shimazaki, MD, PhD, Shinsaku Matsunaga, MD, Ruriko Tanaka, Asumi Yokota, Yoshihide Murotani, MD, Miki Takeuchi, MD, Eri Kawata, MD, Yuri Kamitsuji, MD, Junya Kuroda, MD, PhD, Masafumi Taniwaki, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, PhD

Blood (2007) 110 (11): 1078.

https://doi.org/10.1182/blood.V110.11.1078.1078

Published: 2007

Journal Articles

Reduced Intensity Conditioning (RIC) with Cladribine, Busulfan and 4 Gy Total Body Irradiation (TBI) for Bone Marrow Transplantation (BMT) from an HLA-Matched Unrelated Donor (URD): A Prospective Multi-Institutional Clinical Trial.

Blood (2006) 108 (11): 5397.

https://doi.org/10.1182/blood.V108.11.5397.5397

Published: 2006

Journal Articles

Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

Blood (2005) 106 (8): 2854–2861.

https://doi.org/10.1182/blood-2005-04-1733

Published: 2005

Includes: Supplemental data

Journal Articles

Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)–mismatched family members linked with long-term fetomaternal microchimerism

Blood (2004) 104 (12): 3821–3828.

https://doi.org/10.1182/blood-2004-03-1212

Published: 2004

Journal Articles

Expression of Major Histocompatibility Complex Class I-Related Chain (MIC) on Fresh and Cloned Myeloma Cells.

Masashi Okamoto, Tohru Inaba, Sonoko Nakano, Kyoko Namura, Noriko Yamada, Ryo Uchida, Shin-ichi Fuchida, Akira Okano, Naoya Ochiai, Thomas Spies, Chihiro Shimazaki

Blood (2004) 104 (11): 2465.

https://doi.org/10.1182/blood.V104.11.2465.2465

Published: 2004

Journal Articles

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

Kazutaka Ozeki, Hitoshi Kiyoi, Yuka Hirose, Masanori Iwai, Manabu Ninomiya, Yoshihisa Kodera, Shuichi Miyawaki, Kazutaka Kuriyama, Chihiro Shimazaki, Hideki Akiyama, Miki Nishimura, Toshiko Motoji, Katsuji Shinagawa, Akihiro Takeshita, Ryuzo Ueda, Ryuzo Ohno, Nobuhiko Emi, Tomoki Naoe

Blood (2004) 103 (5): 1901–1908.

https://doi.org/10.1182/blood-2003-06-1845

Published: 2004

Journal Articles

Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro

Naoya Ochiai, Ryo Uchida, Shin-ichi Fuchida, Akira Okano, Masashi Okamoto, Eishi Ashihara, Tohru Inaba, Naohisa Fujita, Hiroaki Matsubara, Chihiro Shimazaki

Blood (2003) 102 (9): 3349–3353.

https://doi.org/10.1182/blood-2003-03-0851

Published: 2003

Journal Articles

Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism

Chihiro Shimazaki, Naoya Ochiai, Ryo Uchida, Akira Okano, Shin-ichi Fuchida, Eishi Ashihara, Tohru Inaba, Naohisa Fujita, Etsuko Maruya, Masao Nakagawa

Blood (2003) 101 (8): 3334–3336.

https://doi.org/10.1182/blood-2002-09-2883

Published: 2003

Journal Articles

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

Blood (2001) 97 (8): 2434–2439.

https://doi.org/10.1182/blood.V97.8.2434

Published: 2001

Journal Articles

Prognostic Implication of FLT3 and N- RAS Gene Mutations in Acute Myeloid Leukemia

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano, Shohei Yokota, Saburo Minami, Shuichi Miyawaki, Norio Asou, Kazutaka Kuriyama, Itsuro Jinnai, Chihiro Shimazaki, Hideki Akiyama, Kenji Saito, Hakumei Oh, Toshiko Motoji, Eijiro Omoto, Hidehiko Saito, Ryuzo Ohno, Ryuzo Ueda

Blood (1999) 93 (9): 3074–3080.

https://doi.org/10.1182/blood.V93.9.3074

Published: 1999

NARROW

Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study

Prognostic Impact of Past History of Other Malignancies in Diffuse Large B Cell Lymphoma

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

Retrospective Analysis Of The Recent Treatment Strategies For The Patients With Myeloma-Related Diseases Registered In Kansai Myeloma Forum

Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65–70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network

Cyclin-Dependent Kinase Inhibitors Enhance Sensitivity to Methotrexate In Human T-Cell Leukemia Jurkat Cells

Expression of Master Regulators of Helper T-Cell Differentiation in Peripheral T-Cell Lymphoma, Not Otherwise Specified by Immunohistochemical Analysis.

ß-Catenin siRNA Successfully Suppressed the Progression of Multiple Myeloma in In Vivo Mouse Model.

Long-Term Survival after HLA-Haploidentical Stem Cell Transplantation from Non-Inherited Maternal Antigen-Mismatched Family Donors: Impact of Chronic Graft-Versus-Host Disease.

Kinetics of Circulating Endothelial Progenitors in Patients with Sclerodermatous Chronic Graft-Versus-Host Disease.

Reduced Intensity Conditioning (RIC) with Cladribine, Busulfan and 4 Gy Total Body Irradiation (TBI) for Bone Marrow Transplantation (BMT) from an HLA-Matched Unrelated Donor (URD): A Prospective Multi-Institutional Clinical Trial.

Clinical Characteristics and Prognostic Implications of NPM1 Mutations in Acute Myeloid Leukemia.

Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)–mismatched family members linked with long-term fetomaternal microchimerism

Expression of Major Histocompatibility Complex Class I-Related Chain (MIC) on Fresh and Cloned Myeloma Cells.

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro

Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

Prognostic Implication of FLT3 and N- RAS Gene Mutations in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only